XML 25 R13.htm IDEA: XBRL DOCUMENT

Share-Based Compensation	9 Months Ended
Share-Based Compensation	Sep. 27, 2025
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation The Company incurred stock-based compensation expense of $3.5 million and $3.2 million in the three fiscal months ended September 27, 2025 and September 28, 2024, respectively, and $8.3 million and $6.9 million in the nine fiscal months ended September 27, 2025 and September 28, 2024, respectively. During the three and nine fiscal months ended September 27, 2025, the Company issued new grants for 2,784 and 296,707 restricted stock units (“RSUs”), respectively, with a weighted-average grant-date fair value of $74.43 and $75.88 per grant. These new RSU grants are scheduled to vest in one year, in three years, or over three years, depending on the terms of each grant, with vesting dependent on service requirements for all awards and market-based conditions for certain awards. Each RSU grant issued during the nine fiscal months ended September 27, 2025 will potentially result in the future issuance of one share of the Company’s common stock if the vesting conditions are satisfied; however, RSUs issued with market-based vesting conditions could vest at rates between 50% and 200%. During the three fiscal months ended September 27, 2025, the three-year performance measurement period concluded for performance-based grants that were issued in fiscal 2022. At the end of the performance measurement period, 40,055 grants (each representing one underlying share of the Company’s common stock) were outstanding. For these 40,055 grants, 5,780 vested and 34,275 were forfeited based on final achievement results for the performance criteria contained in the grants. Under the authorization of the 2021 BlueLinx Holdings, Inc. 2021 Long-Term Incentive Plan, 328,991 shares of the Company’s common stock remain authorized and available for future issuances of equity-based compensation awards as of September 27, 2025.